[ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ] 2020³â 6¿ù ³×Æ®¿öÅ©ºÐ¼®
TF-IDF(´Ü¾î°¡ÁßÄ¡) ºÐ¼®
ÀÓ»óÀÇÇÐºÐ¾ß ´Ü¾î °¡ÁßÄ¡ÀÇ »óÀ§ 10À§ µ¿ÇâÀº Complication, COVID-19, F-18 Fdg Pet, General Surgery, Mortality, Neoplasms, Pain, Risk, Stroke, Women·Î ³ªÅ¸³². ÀÓ»óÀÇÇкоßÀÇ ¿¬±¸µ¿Ç⠺м®À» À§ÇÏ¿© Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbaset)¿¡¼ ÃßÃâµÈ ³í¹®À» ¹ÙÅÁÀ¸·Î Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2020³â 6¿ù¿¡ ¹ßÇ¥ÇÑ ±¹³» Àú³Î ³í¹®°ú ¹Ì±¹ ±¹¸³º¸°Ç¿ø PubMed DB¿¡ À妽ºµÈ ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®À» ºÐ¼®´ë»óÀ¸·Î ÇÏ¿´À½.
±×¸² 1. 6¿ù ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ : ´Ü¾î °¡ÁßÄ¡ ºÐ¼® Å°¿öµå Ŭ¶ó¿ìµå
Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±¹³»¿Í ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥ÇÑ 2020³â 6¿ù ÀÇ°úÇкоßÀÇ ³í¹® Áß¿¡¼ ÀÓ»óÀÇÇкоßÀÇ ³í¹®Àº ±¹³» Àú³Î¹ßÇ¥ 753Æí, ±¹¿Ü Àú³Î¹ßÇ¥(PubMed À妽º±âÁØ) 849ÆíÀ¸·Î ÃÑ 1,602ÆíÀ¸·Î ³ªÅ¸³². ÀÌ´Â Àü¿ù ÀÓ»óÀÇÇÐºÐ¾ß ±¹³»¹ßÇ¥ 786Æí, ±¹¿Ü¹ßÇ¥ 975Æí°ú ºñ±³Çϸé 9.8% (n=159) °¨¼ÒµÈ Ãß¼¼·Î ³ªÅ¸³². 6¿ù ¹ßÇ¥µÈ ÀÇ°úÇÐºÐ¾ß Àüü ³í¹® Áß¿¡¼ ÀÓ»óÀÇÇÐºÐ¾ß ³í¹®ÀÌ Â÷ÁöÇÏ´Â ºñÀ²Àº 67%·Î °¡Àå ³ôÀº ºñÁßÀ» ³ªÅ¸³¿.
±×¸² 2. ÀÓ»óÀÇÇÐ ºÐ¾ß ±¹¿Ü¹ßÇ¥ 5°³ ÅäÇÈ°ú ´Ü¾îµé°£ÀÇ ³×Æ®¿öÅ©
Ç¥ 1. ÀÓ»óÀÇÇÐ : 6¿ù ÅäÇÈ ¸ðµ¨¸µ ÃßÃâ ¿¬±¸µ¿Çâ Å°¿öµå
Topic1
|
Topic2
|
Topic3
|
Topic4
|
Topic5
|
Pain
|
F-18 Fdg Pet
|
Risk
|
Neoplasms
|
Survival Rate
|
Women
|
Sensitivity And Specificity
|
Women
|
Genes
|
General Surgery
|
Breast Neoplasms
|
Liver
|
Serum
|
Role
|
Complication
|
Retinaldehyde
|
Mortality
|
Bmi
|
Humans
|
Risk
|
Prognosis
|
Brain
|
Sex
|
Adolescent
|
Recurrence
|
Biological Markers
|
Radiation
|
Stroke
|
Neoplasm Metastasis
|
Mortality
|
Osteoarthritis
|
Computed Tomography
|
Odds Ratio
|
Inflammation
|
Adult
|
Disability
|
Cicatrix
|
Death
|
Population
|
Pediatrics
|
COVID-19
|
Evaluation Studies As Topic
|
Hypertension
|
Polymerase Chain Reaction
|
Drug Therapy
|
Health Care Costs
|
Bacteremia
|
Risk Factors
|
Family
|
COVID-19
|
6¿ù ÀÓ»óÀÇÇкоßÀÇ ±¹³», ±¹¿Ü ¹ßÇ¥µÈ ¿öµå°¡ÁßÄ¡ °á°ú´Â General Surgery, Women, Risk, COVID-19, Complication, F-18 Fdg Pet, Stroke, Neoplasms, Mortality, Pain, Survival Rate,, Recurrence, Pediatrics, Depression, Drug, Evaluation Studies As Topic, Risk Factors, Liver, Adult, Exercise µîÀÌ ÀÓ»óÀÇÇкоßÀÇ »óÀ§·Î ³ªÅ¸³².
Ç¥ 2. 2020³â 6¿ù ÀÓ»óÀÇÇÐºÐ¾ß TF-IDF(´Ü¾î°¡ÁßÄ¡) ÅäÇÈ Å°¿öµåµ¿Ç⠺м®(N=1,602)
Å°¿öµå ¼øÀ§
|
±¹³»Àú³Î
ÀÓ»óÀÇÇÐ
|
±¹¿ÜÀú³Î
ÀÓ»óÀÇÇÐ
|
ÀÓ»óÀÇÇÐ
¿¬±¸µ¿Çâ Å°¿öµå
|
1
|
General Surgery
|
Risk
|
General Surgery
|
2
|
Women
|
Neoplasms
|
Women
|
3
|
Risk
|
Women
|
Risk
|
4
|
Complication
|
General Surgery
|
COVID-19
|
5
|
COVID-19
|
Survival Rate
|
Complication
|
6
|
F-18 Fdg Pet
|
Complication
|
F-18 Fdg Pet
|
7
|
Stroke
|
Mortality
|
Stroke
|
8
|
Neoplasms
|
Genes
|
Neoplasms
|
9
|
Mortality
|
Role
|
Mortality
|
10
|
Pain
|
F-18 Fdg Pet
|
Pain
|
11
|
Recurrence
|
Serum
|
Survival Rate
|
12
|
Pediatrics
|
Recurrence
|
Recurrence
|
13
|
Depression
|
Drug Therapy
|
Pediatrics
|
14
|
Survival Rate
|
Bmi
|
Depression
|
15
|
Drug
|
Sensitivity & Specificity
|
Drug
|
16
|
Evaluation Studies As Topic
|
Liver
|
Evaluation Studies As Topic
|
17
|
Risk Factors
|
Brain
|
Risk Factors
|
18
|
Liver
|
Pain
|
Liver
|
19
|
Adult
|
Population
|
Adult
|
20
|
Role
|
Death
|
Exercise
|
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ Á¦°ø